World
Why Doctors Are Last to Know What’s in the Drug Supply
The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
Publication and source
PublicationSanalda Haber
SourceTIME
Published
CategoryWorld
Summary from the source publisher’s news feed.